SCHEMBL25767433

SCHEMBL25767433

CCOC(=O)c1nnn(-c2ccccc2F)c1C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.67
ALOX12 P18054 1/20 0.67
NPSR1 Q6W5P4 2/20 0.65
ALDH1A1 P00352 4/20 0.56
MITF O75030 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
KMT2A Q03164 1/20 0.53
MAPT P10636 2/20 0.53
HPGD P15428 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
SLC5A1 P13866 4/20 0.52
SLC5A2 P31639 4/20 0.52
SPR P35270 1/20 0.49
PKM P14618 1/20 0.48
HTT P42858 1/20 0.48
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3457023 0.88 SLC5A1 (0.59) TP53ALOX12NPSR1ALDH1A1MAPT
SCHEMBL20162908 0.86 GAA (0.51) TP53ALOX12NPSR1ALDH1A1KMT2A
SCHEMBL30036841 0.86 GAA (0.51) TP53ALOX12NPSR1ALDH1A1KMT2A
SCHEMBL17321555 0.86 TP53 (0.71) TP53ALOX12NPSR1ALDH1A1MITF
SCHEMBL3455812 0.86 NPSR1 (0.55) TP53ALOX12NPSR1ALDH1A1MITF
SCHEMBL23771920 0.85 NPSR1 (0.57) TP53ALOX12NPSR1ALDH1A1SMN1; SMN2
SCHEMBL19997265 0.84 PTGS2 (0.51) TP53ALOX12NPSR1ALDH1A1MAPT
SCHEMBL3455998 0.84 NPSR1 (0.53) TP53ALOX12NPSR1ALDH1A1KMT2A
SCHEMBL15897945 0.83 TP53 (0.66) TP53ALOX12ALDH1A1MITFSMN1; SMN2
SCHEMBL3455838 0.82 ALDH1A1 (0.57) TP53ALOX12NPSR1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691992-B2 Oxaborole analogs and uses thereof ANACOR PHARMACEUTICALS, INC. (US) 2023-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691992-B2 Oxaborole analogs and uses thereof OXA1L, EPX, OAT TP53 4500/4885ALOX12 275/4885NPSR1 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.